MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2
Authors:
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 105, 922-931
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinomaOncotarget, 2017
- The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL‐1 expression by sponging miR‐363‐3p in gallbladder cancerJournal of Cellular and Molecular Medicine, 2016
- Cancer treatment and survivorship statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expressionOncotarget, 2016
- MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancerBMC Cancer, 2015
- The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesisNature Communications, 2014
- Novel Agents Targeting Bioactive Sphingolipids for the Treatment of CancerCurrent Medicinal Chemistry, 2012
- A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma PatientsCancer Research, 2010
- Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic TargetingCurrent Molecular Pharmacology, 2010
- MicroRNAs and Cancer: Short RNAs Go a Long WayCell, 2009